Cargando…

Emerging SARS-CoV-2 variants: Why, how, and what's next?

The emergence of the SARS-CoV-2 Omicron variant poses a striking threat to human society. More than 30 mutations in the Spike protein of the Omicron variant severely compromised the protective immunity elicited by either vaccination or prior infection. The persistent viral evolutionary trajectory ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu, Liu, Qianyun, Zhou, Li, Zhou, You, Yan, Huan, Lan, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057926/
https://www.ncbi.nlm.nih.gov/pubmed/37193049
http://dx.doi.org/10.1016/j.cellin.2022.100029
_version_ 1784698009093668864
author Chen, Yu
Liu, Qianyun
Zhou, Li
Zhou, You
Yan, Huan
Lan, Ke
author_facet Chen, Yu
Liu, Qianyun
Zhou, Li
Zhou, You
Yan, Huan
Lan, Ke
author_sort Chen, Yu
collection PubMed
description The emergence of the SARS-CoV-2 Omicron variant poses a striking threat to human society. More than 30 mutations in the Spike protein of the Omicron variant severely compromised the protective immunity elicited by either vaccination or prior infection. The persistent viral evolutionary trajectory generates Omicron-associated lineages, such as BA.1 and BA.2. Moreover, the virus recombination upon Delta and Omicron co-infections has been reported lately, although the impact remains to be assessed. This minireview summarizes the characteristics, evolution and mutation control, and immune evasion mechanisms of SARS-CoV-2 variants, which will be helpful for the in-depth understanding of the SARS-CoV-2 variants and policy-making related to COVID-19 pandemic control.
format Online
Article
Text
id pubmed-9057926
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90579262022-05-02 Emerging SARS-CoV-2 variants: Why, how, and what's next? Chen, Yu Liu, Qianyun Zhou, Li Zhou, You Yan, Huan Lan, Ke Cell Insight Review The emergence of the SARS-CoV-2 Omicron variant poses a striking threat to human society. More than 30 mutations in the Spike protein of the Omicron variant severely compromised the protective immunity elicited by either vaccination or prior infection. The persistent viral evolutionary trajectory generates Omicron-associated lineages, such as BA.1 and BA.2. Moreover, the virus recombination upon Delta and Omicron co-infections has been reported lately, although the impact remains to be assessed. This minireview summarizes the characteristics, evolution and mutation control, and immune evasion mechanisms of SARS-CoV-2 variants, which will be helpful for the in-depth understanding of the SARS-CoV-2 variants and policy-making related to COVID-19 pandemic control. Elsevier 2022-05-02 /pmc/articles/PMC9057926/ /pubmed/37193049 http://dx.doi.org/10.1016/j.cellin.2022.100029 Text en © 2022 Published by Elsevier B.V. on behalf of Wuhan University. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Chen, Yu
Liu, Qianyun
Zhou, Li
Zhou, You
Yan, Huan
Lan, Ke
Emerging SARS-CoV-2 variants: Why, how, and what's next?
title Emerging SARS-CoV-2 variants: Why, how, and what's next?
title_full Emerging SARS-CoV-2 variants: Why, how, and what's next?
title_fullStr Emerging SARS-CoV-2 variants: Why, how, and what's next?
title_full_unstemmed Emerging SARS-CoV-2 variants: Why, how, and what's next?
title_short Emerging SARS-CoV-2 variants: Why, how, and what's next?
title_sort emerging sars-cov-2 variants: why, how, and what's next?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057926/
https://www.ncbi.nlm.nih.gov/pubmed/37193049
http://dx.doi.org/10.1016/j.cellin.2022.100029
work_keys_str_mv AT chenyu emergingsarscov2variantswhyhowandwhatsnext
AT liuqianyun emergingsarscov2variantswhyhowandwhatsnext
AT zhouli emergingsarscov2variantswhyhowandwhatsnext
AT zhouyou emergingsarscov2variantswhyhowandwhatsnext
AT yanhuan emergingsarscov2variantswhyhowandwhatsnext
AT lanke emergingsarscov2variantswhyhowandwhatsnext